HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Corneal opacity and cataract: triple procedure versus secondary approach.

AbstractPURPOSE:
To determine the efficacy of planned secondary cataract surgery after keratoplasty.
METHODS:
Twenty patients (22 eyes) with simultaneous corneal pathology and cataract were enrolled in a prospective, interventional, case-matched, nonrandomized comparative trial. Penetrating keratoplasty (PKP) and extracapsular cataract extraction (ECCE) with IOL insertion (triple procedure) were performed in 11 eyes, and planned phacoemulsification (PEA) with IOL insertion after PKP was performed in 11 case-matched eyes.
RESULTS:
There were 10 eyes (91%) within +/-2.0 D of expected values in the secondary PEA group versus 5 patients (45%) in the triple procedure group. No difference was observed in endothelial cell density after 1-year follow-up.
CONCLUSIONS:
Planning for secondary PEA in PKP patients with cataracts is a safe and reliable procedure to obtain less post surgical refractive error. Performing a two-stage intervention has no effect on corneal endothelial viability after 1 year.
AuthorsShigeto Shimmura, Yoshie Ohashi, Hiroki Shiroma, Jun Shimazaki, Kazuo Tsubota
JournalCornea (Cornea) Vol. 22 Issue 3 Pg. 234-8 (Apr 2003) ISSN: 0277-3740 [Print] United States
PMID12658089 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Topics
  • Adult
  • Aged
  • Case-Control Studies
  • Cataract (complications, therapy)
  • Cell Count
  • Corneal Opacity (complications, surgery)
  • Endothelium, Corneal (cytology)
  • Female
  • Humans
  • Keratoplasty, Penetrating (methods)
  • Lens Implantation, Intraocular (methods)
  • Male
  • Middle Aged
  • Phacoemulsification (methods)
  • Prospective Studies
  • Safety
  • Treatment Outcome
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: